GT BIOPHARMA, INC. Cost of Revenue
GT BIOPHARMA, INC. (GTBP) reported Cost of Revenue of $0 for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2018-08-14
- GT BIOPHARMA, INC. cost of goods and services sold for the quarter ending 2018-06-30 was $0.00.
- GT BIOPHARMA, INC. cost of goods and services sold for the quarter ending 2018-03-31 was $0.00.
- GT BIOPHARMA, INC. cost of goods and services sold for the quarter ending 2017-12-31 was $0.00.
- GT BIOPHARMA, INC. cost of goods and services sold for the quarter ending 2017-09-30 was $0.00.
- GT BIOPHARMA, INC. cost of goods and services sold for fiscal 2017 was $0.00.
- GT BIOPHARMA, INC. cost of goods and services sold for fiscal 2016 was $0.00.
- GT BIOPHARMA, INC. cost of goods and services sold for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- GT BIOPHARMA, INC. cost of goods and services sold for fiscal 2014 was $57.00K, a 74.78% decline from fiscal 2013.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2018-06-30 | $0.00 10-Q · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | $0.00 derived: sum of 3 quarters · filed 2018-08-14 | $0.00 derived: sum of 4 quarters · filed 2018-08-14 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 | $0.00 derived: sum of 2 quarters · filed 2018-05-15 | $0.00 derived: sum of 3 quarters · filed 2018-05-15 | $0.00 derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $0.00 derived: sum of 3 quarters · filed 2018-08-14 | $0.00 10-K · filed 2018-03-01 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-08-14 | $0.00 10-Q · filed 2017-11-14 | $0.00 derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | $0.00 derived: sum of 3 quarters · filed 2018-08-14 | $0.00 derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-15 | $0.00 derived: sum of 2 quarters · filed 2018-05-15 | $0.00 derived: sum of 3 quarters · filed 2018-05-15 | $0.00 derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $0.00 derived: sum of 2 quarters · filed 2018-03-01 | $0.00 derived: sum of 3 quarters · filed 2018-03-01 | $0.00 10-K · filed 2018-03-01 |
| 2016-09-30 | $0.00 10-Q/A · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 10-Q/A · filed 2018-02-28 | $0.00 derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $0.00 10-Q/A · filed 2018-02-28 | $0.00 10-Q/A · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $0.00 10-Q/A · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 10-K/A · filed 2018-02-28 |
| 2015-09-30 | $0.00 10-Q/A · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 10-Q/A · filed 2018-02-28 | $35.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-06-30 | $0.00 10-Q/A · filed 2018-02-28 | $0.00 10-Q/A · filed 2018-02-28 | $35.00K derived: sum of 3 quarters · filed 2018-02-28 | $40.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-03-31 | $0.00 10-Q/A · filed 2018-02-28 | $35.00K derived: sum of 2 quarters · filed 2018-02-28 | $40.00K derived: sum of 3 quarters · filed 2018-02-28 | $57.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2014-12-31 | $35.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28 | $40.00K derived: sum of 2 quarters · filed 2018-02-28 | $57.00K derived: sum of 3 quarters · filed 2018-02-28 | $57.00K 10-K/A · filed 2018-02-28 |
| 2014-09-30 | $5.00K 10-Q · filed 2015-11-13 | $22.00K derived: sum of 2 quarters · filed 2015-11-13 | $22.00K 10-Q · filed 2015-11-13 | $44.00K derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | $17.00K 10-Q · filed 2015-08-14 | $17.00K 10-Q · filed 2015-08-14 | $39.00K derived: sum of 3 quarters · filed 2015-08-14 | $162.00K derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | $22.00K derived: sum of 2 quarters · filed 2015-05-14 | $145.00K derived: sum of 3 quarters · filed 2015-05-14 | $157.00K derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $145.00K derived: sum of 2 quarters · filed 2015-03-31 | $157.00K derived: sum of 3 quarters · filed 2015-03-31 | $226.00K 10-K · filed 2015-03-31 |
| 2013-09-30 | $123.00K 10-Q · filed 2014-12-17 | $135.00K derived: sum of 2 quarters · filed 2015-01-08 | $204.00K 10-Q · filed 2015-01-08 | $265.00K derived: sum of 4 quarters · filed 2015-01-08 |
| 2013-06-30 | $12.00K 10-Q · filed 2015-01-08 | $81.00K 10-Q · filed 2015-01-08 | $142.00K derived: sum of 3 quarters · filed 2015-01-08 | $174.00K derived: sum of 4 quarters · filed 2015-01-08 |
| 2013-03-31 | $69.00K 10-Q · filed 2015-01-08 | $130.00K derived: sum of 2 quarters · filed 2015-01-08 | $162.00K derived: sum of 3 quarters · filed 2015-01-08 | $162.00K derived: sum of 4 quarters · filed 2015-01-08 |
| 2012-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | $93.00K derived: sum of 2 quarters · filed 2015-01-08 | $93.00K derived: sum of 3 quarters · filed 2015-01-08 | $94.00K 10-K · filed 2015-01-08 |
| 2012-09-30 | $32.00K 10-Q · filed 2014-12-17 | $32.00K derived: sum of 2 quarters · filed 2014-12-17 | $33.00K 10-Q · filed 2014-12-17 | $33.00K derived: sum of 4 quarters · filed 2014-12-17 |
| 2012-06-30 | $0.00 10-Q · filed 2014-12-12 | $1.00K 10-Q · filed 2014-12-12 | $1.00K derived: sum of 3 quarters · filed 2014-12-12 | $9.00K derived: sum of 4 quarters · filed 2014-12-12 |
| 2012-03-31 | $1.00K 10-Q · filed 2014-12-10 | $1.00K derived: sum of 2 quarters · filed 2014-12-10 | $9.00K derived: sum of 3 quarters · filed 2014-12-10 | $24.00K derived: sum of 4 quarters · filed 2014-12-10 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | $8.00K derived: sum of 2 quarters · filed 2014-11-18 | $23.00K derived: sum of 3 quarters · filed 2014-11-18 | $48.00K 10-K · filed 2014-11-18 |
| 2011-09-30 | $8.00K 10-Q · filed 2012-11-21 | $23.00K derived: sum of 2 quarters · filed 2012-11-21 | $48.00K 10-Q · filed 2012-11-21 | $113.00K derived: sum of 4 quarters · filed 2012-11-21 |
| 2011-06-30 | $15.00K 10-Q/A · filed 2012-09-13 | $40.00K 10-Q/A · filed 2012-09-13 | $105.00K derived: sum of 3 quarters · filed 2012-09-13 | $105.00K derived: sum of 4 quarters · filed 2012-09-13 |
| 2011-03-31 | $25.00K 10-Q · filed 2012-05-21 | $90.00K derived: sum of 2 quarters · filed 2012-05-21 | $90.00K derived: sum of 3 quarters · filed 2012-05-21 | $90.00K derived: sum of 4 quarters · filed 2012-05-21 |
| 2010-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $65.00K derived: sum of 2 quarters · filed 2012-04-16 | $65.00K derived: sum of 3 quarters · filed 2012-04-16 | $65.00K 10-K · filed 2012-04-16 |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-21 | $0.00 derived: sum of 2 quarters · filed 2011-11-21 | $0.00 10-Q · filed 2011-11-21 | |
| 2010-06-30 | $0.00 10-Q/A · filed 2011-09-12 | $0.00 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |